Table 4.
Prevalence of cardiometabolic risk factors according to body mass index (BMI).
| Variables | Group I |
Group II |
Group III |
||||||
|---|---|---|---|---|---|---|---|---|---|
| BMI (18.5–22.9 kg/m2) | BMI (23–24.9 kg/m2) | BMI (>25 kg/m2) | |||||||
| Gender wise numbers | Male (n = 194) | Female (n = 167) | Total (n = 361) | Male (n = 126) | Female (n = 91) | Total (n = 217) | Male (n = 234) | Female (n = 282) | Total (n = 516) |
| Impaired fasting glucose | 26 (13.4)a,b | 15 (9.0)b | 36 (11.4)a,b | 23 (18.3)c | 15 (16.5)c | 38 (17.5)c | 66 (28.2) | 72 (25.5) | 138 (26.7) |
| Impaired glucose tolerance | 22 (11.3)a,b | 11 (6.6)a,b | 33 (9.1)a,b | 24 (19.0)c | 10 (11.0)c | 34 (15.7)c | 55 (23.5) | 63 (22.3) | 118 (22.9) |
| Diabetes | 27 (13.9)a,b | 9 (5.4)a,b | 36 (10.0)a,b | 24 (19.0) | 10 (11.0)c | 34 (15.7)c | 52 (22.2) | 60 (21.3) | 112 (21.7) |
| Hypertension | 55 (28.4)a,b | 32 (19.2)a | 87 (24.1)a,b | 51 (40.5)c | 30 (33.0)c | 81 (37.3)c | 114 (48.7) | 135 (47.9) | 249 (48.3) |
| Metabolic syndrome | 29 (14.9)a,b | 39 (23.4)a,b | 68 (18.8)a,b | 45 (35.7)c | 49 (53.8)c | 94 (43.3)c | 127 (54.3) | 214 (75.9) | 341 (66.1) |
Values are shown as no (%).
a
Group I versus II; statistical significance at the P < 0.05 level.
b
Group I versus III; all statistical significant (P < 0.05).
c
Group II versus III statistical significance (P < 0.05).